Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Selling, General & Administrative
Meridian Bioscience Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Selling, General & Administrative
-$88.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Selling, General & Administrative
-$1.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Selling, General & Administrative
-$1.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-19%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Selling, General & Administrative
-$304.7m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-16%
|
See Also
What is Meridian Bioscience Inc's Selling, General & Administrative?
Selling, General & Administrative
-88.4m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Selling, General & Administrative amounts to -88.4m USD.
What is Meridian Bioscience Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-7%
Over the last year, the Selling, General & Administrative growth was -16%. The average annual Selling, General & Administrative growth rates for Meridian Bioscience Inc have been -13% over the past three years , -7% over the past five years .